Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 7 | 2020 | 5725 | 1.190 |
Why?
|
| Contact Tracing | 2 | 2016 | 244 | 0.940 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2020 | 1809 | 0.900 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2019 | 58 | 0.810 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2016 | 535 | 0.790 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2018 | 290 | 0.640 |
Why?
|
| DNA Methylation | 2 | 2019 | 3987 | 0.580 |
Why?
|
| Th2 Cells | 1 | 2020 | 1036 | 0.570 |
Why?
|
| Eosinophils | 1 | 2018 | 929 | 0.520 |
Why?
|
| Organoplatinum Compounds | 1 | 2015 | 449 | 0.520 |
Why?
|
| Neuropeptides | 1 | 2019 | 935 | 0.520 |
Why?
|
| Drug Resistance | 1 | 2019 | 1617 | 0.490 |
Why?
|
| Carboplatin | 1 | 2015 | 807 | 0.460 |
Why?
|
| Sexual Partners | 1 | 2016 | 699 | 0.460 |
Why?
|
| Drug Hypersensitivity | 2 | 2020 | 845 | 0.440 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 1794 | 0.410 |
Why?
|
| Homosexuality, Male | 1 | 2016 | 1052 | 0.360 |
Why?
|
| Administration, Inhalation | 3 | 2020 | 1119 | 0.350 |
Why?
|
| Circumcision, Male | 1 | 2009 | 155 | 0.350 |
Why?
|
| Mass Media | 1 | 2009 | 326 | 0.310 |
Why?
|
| IgG Deficiency | 1 | 2020 | 28 | 0.220 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2020 | 96 | 0.200 |
Why?
|
| China | 2 | 2016 | 2250 | 0.180 |
Why?
|
| Placebo Effect | 1 | 2020 | 584 | 0.150 |
Why?
|
| Desensitization, Immunologic | 2 | 2020 | 461 | 0.140 |
Why?
|
| CpG Islands | 1 | 2019 | 1151 | 0.140 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1700 | 0.140 |
Why?
|
| False Negative Reactions | 1 | 2015 | 617 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2020 | 747 | 0.130 |
Why?
|
| Respiratory Function Tests | 1 | 2018 | 1709 | 0.130 |
Why?
|
| Forced Expiratory Volume | 1 | 2019 | 1739 | 0.130 |
Why?
|
| Skin Tests | 1 | 2015 | 670 | 0.130 |
Why?
|
| Child | 5 | 2020 | 71361 | 0.120 |
Why?
|
| Treponema pallidum | 1 | 2011 | 48 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 952 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2020 | 1363 | 0.110 |
Why?
|
| Molecular Typing | 1 | 2011 | 119 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1971 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 1081 | 0.100 |
Why?
|
| Syphilis | 1 | 2011 | 208 | 0.100 |
Why?
|
| Male | 10 | 2020 | 352465 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2012 | 487 | 0.090 |
Why?
|
| Prognosis | 2 | 2020 | 28923 | 0.090 |
Why?
|
| Cervix Uteri | 1 | 2012 | 564 | 0.090 |
Why?
|
| Africa South of the Sahara | 1 | 2009 | 648 | 0.080 |
Why?
|
| Humans | 14 | 2020 | 686663 | 0.080 |
Why?
|
| Adult | 7 | 2020 | 211400 | 0.080 |
Why?
|
| Double-Blind Method | 1 | 2020 | 11866 | 0.080 |
Why?
|
| Bibliometrics | 1 | 2009 | 310 | 0.080 |
Why?
|
| Female | 8 | 2020 | 375459 | 0.070 |
Why?
|
| Papillomaviridae | 1 | 2012 | 1080 | 0.070 |
Why?
|
| Cytokines | 1 | 2020 | 7147 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2020 | 60991 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2020 | 3587 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 56052 | 0.070 |
Why?
|
| HIV Infections | 1 | 2009 | 14979 | 0.070 |
Why?
|
| Proteins | 1 | 2019 | 6264 | 0.060 |
Why?
|
| Adolescent | 3 | 2020 | 84957 | 0.060 |
Why?
|
| Risk | 1 | 2015 | 9915 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 15407 | 0.060 |
Why?
|
| Disease Progression | 1 | 2019 | 13204 | 0.060 |
Why?
|
| Massachusetts | 1 | 2015 | 8920 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2012 | 1371 | 0.050 |
Why?
|
| Lung | 1 | 2019 | 9182 | 0.050 |
Why?
|
| Genotype | 2 | 2012 | 13073 | 0.050 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 288 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 641 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 608 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 627 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 1939 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2020 | 628 | 0.030 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2012 | 36 | 0.030 |
Why?
|
| Phylogeography | 1 | 2011 | 88 | 0.030 |
Why?
|
| Women, Working | 1 | 2012 | 79 | 0.030 |
Why?
|
| United States | 1 | 2018 | 65579 | 0.030 |
Why?
|
| Asia | 1 | 2012 | 660 | 0.030 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 489 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4297 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 2625 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 67320 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 8182 | 0.020 |
Why?
|
| Age Distribution | 1 | 2012 | 2963 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 216468 | 0.020 |
Why?
|
| Women's Health | 1 | 2012 | 1882 | 0.010 |
Why?
|
| Age Factors | 1 | 2020 | 19295 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2020 | 38732 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 14744 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 69278 | 0.000 |
Why?
|
Concepts
(88)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_